Jiang, M., & van der Stelt, M. (2018). Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders. J Med Chem.
Citação norma ChicagoJiang, Ming, and Mario van der Stelt. "Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders." J Med Chem 2018.
MLA CitationJiang, Ming, and Mario van der Stelt. "Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders." J Med Chem 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.